Hair loss as a sign of Kawasaki disease.

Department of Allergy and Immunology, Pediatric Ward-Namazee Hospital, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Iranian journal of allergy, asthma, and immunology (Impact Factor: 0.65). 01/2007; 5(4):199-200.
Source: PubMed

ABSTRACT Kawasaki disease is a multi system disorder with varying clinical expressions. This disease is an acute systemic vasculitis of unknown etiology that has recently recognized as a leading cause of acquired heart disease in children of many developed countries. We describe an unusual instance of hair loss in a patient with Kawasaki disease. A 26 months old boy developed prolonged high fever, bilateral conjunctival infection, arthralgia and erythromatosis skin rash. He was admitted to the hospital with the diagnosis of Kawasaki disease. Laboratory results included an erythrocyte sedimentation rate (ESR) above 100 and platelet count > 1000,000. The patient developed acute and unprovoked scalp hair loss. He was treated with intravenous immunoglobulin (IVIG) 2 g/kg and aspirin 100 mg/kg/day with complete improvement of signs and symptoms. This report documents hair loss as an uncommon presentation of Kawasaki disease.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A 10-year-old boy presented with fever, stiff neck, and rash over the legs. During the course of his hospital stay, the clinical picture gradually evolved, and he met the criteria for Kawasaki disease (KD) on the seventh day of hospitalization. During this period, he also developed alopecia areata. He was managed with intravenous immunoglobulin, aspirin, and intralesional triamcinolone. This is the first case of alopecia areata with KD in the literature, and it does not appear to be a mere coincidence. We discuss the probable mechanisms of alopecia areata with KD, an association that has not been reported before.
    Pediatric Dermatology 09/2011; 29(4):532-4. · 1.04 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Kawasaki disease, or mucocutaneous lymph node syndrome, most commonly affects children between 6 months and 5 years of age. Approximately 90% of patients have mucocutaneous manifestations. This article will focus on the epidemiology of Kawasaki disease in the United States as it relates to other countries, the diagnosis of Kawasaki disease, its clinical course, and the currently accepted theories of pathogenesis. A particular focus is given to the various dermatologic manifestations that may occur.
    Journal of the American Academy of Dermatology 10/2013; 69(4):501.e1-501.e11. · 4.91 Impact Factor

Full-text (2 Sources)

Available from
May 29, 2014